About
Synucleinopathy Diagnostic
Areas of Focus
Categories
DiagnosticsSouthwestern U.S.
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
1,048
By Status
RECRUITING: 3ACTIVE_NOT_RECRUITING: 2NOT_YET_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07217054Lead Sponsor
Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
N/ANot yet recruiting
40 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2029
NCT07204652Lead Sponsor
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
N/ARecruiting
20 participants
Started: Sep 3, 2025 · Completed: Sep 30, 2029
NCT06621602Lead Sponsor
Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease
N/ARecruiting
100 participants
Started: Dec 17, 2024 · Completed: Apr 30, 2026
NCT07005947Lead Sponsor
Long COVID Cutaneous Signatures: An ARPA Funded Research Project
N/ARecruiting
300 participants
Started: Nov 30, 2023 · Completed: Dec 31, 2025
NCT05757206Lead Sponsor
The Syn-Sleep Study
N/AActive, not recruiting
80 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2025
Locations (1)
Headquarters
Scottsdale, AZ, United States
Map
Loading map...